Skip to main content
. Author manuscript; available in PMC: 2015 Jul 23.
Published in final edited form as: JAMA. 2013 Apr 24;309(16):1696–1703. doi: 10.1001/jama.2013.2270

Table 3.

Association Between Epilepsy in the Mother, Valproate Exposure, and Autism Spectrum Disorder and Childhood Autism

Epilepsy in Mother Valproate Exposure Live Births, No. No. With Disorder Hazard Ratio (95% Cl)
Absolute Risk Over 14 y, % (95% CI)
Crude Adjusteda
Autism Spectrum Disorder
Yes Yes 432 11 1.7 (0.9-3.2) 1.7 (0.9-3.2) 4.15 (2.20-7.81)

No 6152 83 1 [Reference] 1 [Reference] 2.44 (1.88-3.16)

No Yes 76 3 4.2 (1.4-12.5) 4.4 (1.4-13.6) 6.67 (2.12-20.6)

No 648 955 5340 1 [Reference] 1 [Reference] 1.52 (1.46-1.57)

Childhood Autism
Yes Yes 432 8 2.8 (1.3-6.1) 2.9 (1.4-6.0) 2.95 (1.42-6.11)

No 6152 37 1 [Reference] 1 [Reference] 1.02 (0.70-1.49)

No Yes 76 1 4.2 (0.6-30.0) 3.9 (0.5-28.9) 1.86 (0.24-13.8)

No 648 955 2021 1 [Reference] 1 [Reference] 0.48 (0.45-0.51)
a

Adjusted for maternal age at conception, paternal age at conception, parental psychiatric history, gestational age, birth weight, sex, congenital malformations, and parity.